# Candel Therapeutics, Inc.: Form 8-K, filed May 23, 2024

- Company: [Candel Therapeutics, Inc.](/companies/cadl.md) (CIK 1841387)
- Form: 8-K
- Filed: 2024-05-23
- Accepted by EDGAR: May 23, 2024, 21:05 ET
- Period: 2024-05-23
- Accession: 0000950170-24-064022
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1841387/000095017024064022/cadl-20240523.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1841387/000095017024064022/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1841387/000095017024064022/cadl-20240523.htm

Filed May 23, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-064022. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.